PF-06649751

PF-06649751 · Pfizer

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for PF-06649751, covering 2014-03-26 to 2019-04-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations [Phase 2]